Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NAT6 |
| Upstream (Parents) |
|---|
| (<<) TFEB → NAT6 |
| (<<) PHGDH → NAT6 |
| (<<) CNTLN → NAT6 |
| (<<) ALPL → NAT6 |
| (<<) ZNF324 → NAT6 |
| (<<) TAS2R4 → NAT6 |
| (<<) SOD3 → NAT6 |
| (<<) PPDPF → NAT6 |
| (<<) NDRG1 → NAT6 |
| Downstream (Children) |
|---|
| NAT6 → GRIP2 (>>) |
| NAT6 → PICALM (>>) |
| NAT6 → TAS2R4 (>>) |
| NAT6 → POLL (>>) |
